Zevra Therapeutics
Price & Volume
Stats
See moreOpen | $13.17 |
Previous Close | $13.08 |
Day Range | $13.12-$13.44 |
52W Range | $7.16-$14.27 |
Market Cap | $768.4M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $122.2M |
Revenue Growth (YoY) | 77.5% |
Gross Profit (12 Mos) | $105.2M |
Diluted EPS | $2.01 |
News
See moreYahoo Finance • 8 days ago
As U.S. profit margins near record highs, these small-cap stocks lead on profitability
Yahoo Finance • 28 days ago
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference
Yahoo Finance • 3 months ago
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
About
CEO | Mr. Neil F. McFarlane |
CFO | Mr. Justin A. Renz CPA, MBA |
Address | 101 Federal Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |